The Patient Perspective of Living With Recurrent Respiratory Papillomatosis
The Laryngoscope · 2026
DOI: 10.1002/lary.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Sara I Pai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Respiratory Tract Infections, Cost of Illness, Reinfection. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Sharp and Dohme France.
Abstract (Originalsprache)
Objective
Recurrent Respiratory Papillomatosis (RRP) is caused by human papillomavirus (HPV) types 6 and 11, and afflicts children (Jo‐RRP, Juvenile‐onset RRP) and adults (Ao‐RRP, adult‐onset RRP). The study objective was to describe the disease burden of RRP from three patient‐relevant perspectives: economic, clinical, and humanistic.
Methods
A retrospective descriptive analysis of responses to questionnaires captured within a linked Coordination of Rare Diseases (CoRDS) and the Recurrent Respiratory Papillomatosis Foundation (RRPF) (CoRDS/RRPF) patient registries from May 1, 2019, to July 31, 2023 was performed. Categorical variables were summarized using counts and proportions and continuous variables were summarized using means (standard deviations) and medians (interquartile ranges).
Results
Responses from 122 participants, 55% (67/122) Jo‐RRP and 45% (55/122) Ao‐RRP, were included. Forty‐one percent (41/99) traveled more than 100 miles round trip to receive specialty care, and 61% (52/85) spent > 5% of their family income to pay for care. RRP resulted in increased absences from school [94% (17/18) for participants aged < 22] and work [85.5% (65/76) for participants aged > 22]. Moreover, 64.9% (48/74) of respondents perceived that RRP negatively impacted their careers. Feelings of isolation (70%) and depression (45.1%) were common, but less than 25% of respondents reported seeking mental health assistance.
Conclusion
RRP leads to clinical, financial, and psychosocial burdens. Increased public awareness regarding HPV infection of the airway is needed, as this disease is preventable through HPV vaccination. Level of Evidence 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale University School of Medicine, New Haven, Connecticut, USA.
- MedNavigate, Skokie, Illinois, USA.
- Merck & Co., Inc., Rahway, New Jersey, USA.
- Recurrent Respiratory Papillomatosis Foundation, Langhorne, Pennsylvania, USA.
- MSD, Lyon, France.
ORCID-Profile: Sara I Pai
Förderung
- Merck Sharp and Dohme France
Zitieren
APA
Pai, S. I., Ochieng, W., Hedlund, N., Martino, A., Chohan, N., Pawlak, M., Morais, E., & McClellan, K. (2026). The Patient Perspective of Living With Recurrent Respiratory Papillomatosis. The Laryngoscope. https://doi.org/10.1002/lary.70412
Vancouver
Pai SI, Ochieng W, Hedlund N, Martino A, Chohan N, Pawlak M, et al. The Patient Perspective of Living With Recurrent Respiratory Papillomatosis. The Laryngoscope. 2026. doi:10.1002/lary.70412
BibTeX
@article{Pai2026,
author = {Pai, Sara I and Ochieng, Walter and Hedlund, Nancy and Martino, Amanda and Chohan, Neha and Pawlak, Mir and Morais, Edith and McClellan, Kim},
title = {The Patient Perspective of Living With Recurrent Respiratory Papillomatosis},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70412}
}
EUVIMED